Pres, CFO
Christine Mikail Cvijic is the President and Chief Financial Officer (CFO) of Neurogene Inc. (NASDAQ: NGNE), a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases.[[2]](https://www.investing.com/news/insider-trading-news/neurogene-president-buys-491400-in-company-stock-93CH-3741217)[[3]](https://whalewisdom.com/filing/cvijic-christine-mikail-4-2026-03-03-170353-0500-ngne) Based at Neurogene's office at 535 W 24th Street, 5th Floor, New York, NY 10011, she has demonstrated confidence in the company's future through significant insider purchases, including 24,000 shares acquired on November 22, 2024, at an average price of $20.475, increasing her holdings to 76,844 shares (some jointly owned with her spouse, David Cvijic).[[1]](https://www.quiverquant.com/news/Insider+Purchase:+President+and+CFO+of+$NGNE+(NGNE)+Buys+24,000+Shares)[[2]](https://www.investing.com/news/insider-trading-news/neurogene-president-buys-491400-in-company-stock-93CH-3741217)[[4]](https://www.gurufocus.com/insider/79753/christine-mikail-cvijic) More recent SEC filings show her ownership growing to approximately 105,798 shares as of early 2026, following routine tax-related share sales of 4,045 shares on March 13, 2026, to cover RSU vesting obligations, with additional unvested RSUs scheduled through 2029.[[3]](https://whalewisdom.com/filing/cvijic-christine-mikail-4-2026-03-03-170353-0500-ngne)[[5]](https://www.stocktitan.net/sec-filings/NGNE/form-4-neurogene-inc-insider-trading-activity-009892e0139f.html)
Prior to Neurogene, Cvijic served as Chief Administrative Officer and General Counsel at Sio Gene Therapies Inc. (SIOX), highlighting her extensive experience in biotechnology administration, finance, and legal affairs.[[4]](https://www.gurufocus.com/insider/79753/christine-mikail-cvijic) Her career reflects a strong track record in gene therapy and biopharma sectors, with ongoing insider ownership valued at over $2 million in NGNE stock as of late 2024.[[4]](https://www.gurufocus.com/insider/79753/christine-mikail-cvijic)
View full insider profile →